Accardi Mario Alberto 4
4 · Centessa Pharmaceuticals plc · Filed Dec 8, 2025
Insider Transaction Report
Form 4
Accardi Mario Alberto
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2025-12-08$9.53/sh+5,000$47,650→ 198,801 total - Sale
Ordinary Shares
2025-12-08$30.00/sh−10,000$300,000→ 188,801 total - Exercise/Conversion
Share Option (right to buy)
2025-12-08−5,000→ 6,250 totalExercise: $9.53Exp: 2032-02-01→ Ordinary Shares (5,000 underlying)
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2025.
- [F3]1/48th of the shares subject to such option shall vest and become exercisable in substantially equal monthly installments with the first installment vesting on March 1, 2022.